Merit Medical targets $4.33-$4.37 non-GAAP EPS in 2026 while adding Solo Pace for ~$45M

Merit Medical Systems (MMSI) reported a 8.4% increase in revenue for the third quarter of 2026, reaching $416.2 million. Non-GAAP earnings per share grew 21.7% to $1.12. The results outperformed market expectations and reflected steady growth across product lines and geographies. The company's full-year earnings guidance was raised as a result.

Operating margin improved to 14.1% from 11.1%, and non-GAAP operating margin expanded to 21.3%, up 160 basis points. Revenue grew 8.9% on a constant currency basis year-to-date, indicating sustained momentum. Despite gross margin pressures from raw material costs and freight expenses, the company's disciplined expense management showed strong operating performance.